IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,835 | -95.5% | 6,525 | -95.1% | 0.00% | -100.0% |
| Q2 2023 | $1,403,692 | -51.2% | 131,926 | -51.8% | 0.00% | -60.0% |
| Q1 2023 | $2,879,302 | +30.1% | 273,698 | +53.3% | 0.01% | +25.0% |
| Q4 2022 | $2,212,692 | -27.1% | 178,587 | -39.1% | 0.00% | -20.0% |
| Q3 2022 | $3,037,000 | -6.5% | 293,204 | +4.1% | 0.01% | 0.0% |
| Q2 2022 | $3,248,000 | -72.6% | 281,720 | -70.2% | 0.01% | -66.7% |
| Q1 2022 | $11,874,000 | +8.1% | 943,938 | +0.2% | 0.02% | +25.0% |
| Q4 2021 | $10,984,000 | – | 942,048 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |